Volume 11, Number 10—October 2005
Community-associated Methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003
|Site or manifestation||No. (%)|
|Invasive infection site (n = 65)|
|Without focus||25 (38)|
|With skin focus||6 (9)|
|With respiratory focus||2 (3)|
|Pleural fluid||3 (5)|
|Peritoneal fluid||2 (3)|
|Skin and soft tissue clinical manifestation (n = 511†)|
|Wound infection||27 (5)|
*Other invasive isolate sources included brain tissue (1), lymph nodes (2), pancreatic aspirate (1), kidney abscess aspirate (1), and internal tissue (1).
†A total of 411 skin and soft tissue infection patients had clinical manifestations reported. Results include multiple clinical manifestations per patient.
‡Other skin clinical manifestations included psoriasis, mastitis, cystic acne, furuncles, carbuncles, insect/spider bites, and eczema.
- Page created: February 22, 2012
- Page last updated: February 22, 2012
- Page last reviewed: February 22, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)